Literature DB >> 15671029

Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.

Anthony M Vertino1, Craig M Bula, Jin-Ran Chen, Maria Almeida, Li Han, Teresita Bellido, Stavroula Kousteni, Anthony W Norman, Stavros C Manolagas.   

Abstract

Because sex steroids regulate the life span of bone cells by modulating cytoplasmic kinase activity via a nongenotropic action of their classical receptors, we have explored the possibility that the vitamin D nuclear receptor (VDR) might exhibit similar nongenotropic actions. We report that the conformationally flexible full VDR agonist, 1alpha,25(OH)2-vitamin D3 (1alpha,25(OH)2D3), and the 6-s-cis-locked 1alpha,25(OH)2-lumisterol3 (JN) analog, also acting through the VDR but with poor transcriptional activity, protected murine osteoblastic or osteocytic cells from apoptosis. This effect was reproduced in HeLa cells transiently transfected with either wild type VDR or a mutant consisting of only the VDR ligand binding domain. The VDR ligand binding domain bound [3H]1alpha,25(OH)2D3 as effectively as wild type VDR but did not induce vitamin D response element-mediated transcription. The anti-apoptotic effects of 1alpha,25(OH)2D3 and the 6-s-cis-locked 1alpha,25(OH)2-lumisterol3 analog in calvaria cells were blocked by three cytoplasmic kinase inhibitors: Src kinase inhibitor 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP1), phosphatidylinositol 3 kinase inhibitor Wortmannin, and the JNK kinase inhibitor SP600125. However, inhibition of p38 with SB203580 or ERK with either U0126 or a transfected dominant negative MEK did not interfere with these anti-apoptotic actions. Further, 1alpha,25(OH)2D3 induced rapid (5 min) association of VDR with Src kinase in OB-6 cells. Finally, actinomycin D or cycloheximide prevented the anti-apoptotic effect of 1alpha,25(OH)2D3, indicating that transcriptional events are also required. These findings suggest that nongenotropic modulation of kinase activity is also a general property of the VDR and that ligands that activate nongenotropic signals, but lack transcriptional activity, display different biological profiles from the steroid hormone 1alpha,25(OH)2D3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671029     DOI: 10.1074/jbc.M410720200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  1alpha,25(OH)2-vitamin D3 membrane-initiated calcium signaling modulates exocytosis and cell survival.

Authors:  Zhang Xiaoyu; Biswas Payal; Owraghi Melissa; Laura P Zanello
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-08       Impact factor: 4.292

Review 2.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

3.  Interaction between vitamin D receptor with caveolin-3 and regulation by 1,25-dihydroxyvitamin D3 in adult rat cardiomyocytes.

Authors:  Guisheng Zhao; Robert U Simpson
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-19       Impact factor: 4.292

4.  1alpha,25(OH)(2) vitamin D(3) induction of ATP secretion in osteoblasts.

Authors:  Payal Biswas; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

5.  Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells.

Authors:  Allan M Ramirez; Cherry Wongtrakool; Teresa Welch; Andreas Steinmeyer; Ulrich Zügel; Jesse Roman
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-17       Impact factor: 4.292

Review 6.  Rapid signaling by steroid receptors.

Authors:  Ellis R Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-10       Impact factor: 3.619

7.  Vitamin D receptor-dependent 1 alpha,25(OH)2 vitamin D3-induced anti-apoptotic PI3K/AKT signaling in osteoblasts.

Authors:  Xiaoyu Zhang; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

8.  1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.

Authors:  Wei Wu; Xiaoyu Zhang; Laura P Zanello
Journal:  Cancer Lett       Date:  2007-04-06       Impact factor: 8.679

9.  Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase.

Authors:  Shuo Geng; Shuanhu Zhou; Julie Glowacki
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

10.  Impaired bone formation in Pdia3 deficient mice.

Authors:  Yun Wang; Alexandr Nizkorodov; Kelsie Riemenschneider; Christopher S D Lee; Rene Olivares-Navarrete; Zvi Schwartz; Barbara D Boyan
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.